Resource Library

Check out this whitepaper developed by Foley & Lardner LLP to learn more about the top twelve trends in the digital assets space.

This article provides key considerations for telehealth providers in mapping out how to deliver care on a multi-state basis in light of the Dobbs decision and related state legislation.

Learn more about the new Special Fraud Alert published by the Office of Inspector General, U.S. Department of Health and Human Services on arrangements with telemedicine companies, setting forth seven characteristics OIG believes could suggest a given arrangement poses a heighted risk of fraud and abuse.

Many California health care providers, including hospitals and physician groups, will soon be required to sign on to California’s first-ever statewide data sharing agreement governing the exchange of health and social services information. Learn more here.

The Center for Medicare and Medicaid Innovation (CMMI) is launching a long awaited new oncology model, the Enhancing Oncology Model (EOM). Learn more about the successor to the Oncology Care Model (OCM), which ended June 30, 2022, here.

Implications of US Supreme Court's decision in Dobbs v. Jackson Women's Health Organization for employers in the United States

Read about the Implications for in-house counsel of the US Supreme Court's decision in Dobbs v. Jackson Women's Health Organization in a selection of resources.

Health care providers that provide a full spectrum of women’s health care services, including abortion, will need to understand how the Dobbs decision impacts the care they can provide to patients. Absent a federal protection of a patient’s ability to obtain an abortion, providers operating in this space will need to understand the scope of State laws that apply to abortion services.

In the wake of the US Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, employers with health plans that cover abortion services will have to determine whether or how to provide continued access to this relatively little-used benefit, especially in states that will automatically restrict abortion access now that the ruling has been issued, or that are expected to do so.

The Centers for Medicare and Medicaid Services (CMS) has announced that it “fully expects” to reverse
Medicare Part B rate cuts for separately payable drugs acquired through the 340B Drug Pricing Program,
resulting in an estimated additional $1.96 billion for 340B hospitals. Learn more through this blog post released by Foley & Lardner.